Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04198194 · ClinicalTrials.gov registry record

Apple Heart & Movement Study

A clinical trial of Prevention, sponsored by Apple.

Active
Registry status
500,000
Enrollment target
1
Study location

NCT04198194 is a study of Prevention that is active but no longer recruiting, run by Apple. The registered enrollment target is 500,000 participants, above the 4,538-participant average among 11 other Prevention trials with a reported enrollment target (10918% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04198194, a study of Prevention, is active but no longer recruiting, sponsored by Apple.

ACTIVE NOT RECRUITING
Registry status
500,000 participants
Enrollment target
1
Study location

Study Summary

This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Predictors of events

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 500,000 participants
Start Date 2019-11-14
Est. Completion 2025-02-28

Sponsor

Apple

12 total trials

What the Registry Record Tells You About NCT04198194

The ClinicalTrials.gov registry entry for NCT04198194 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,538-participant average among 11 other Prevention trials with a reported enrollment target (10918% higher). The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prevention appearing as the primary indexed condition, and to 1 intervention - of which Predictors of events is the first listed.

NCT04198194 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04198194 about?

NCT04198194 is a clinical study titled "Apple Heart & Movement Study". This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that wi...

What is the current status of trial NCT04198194?

This trial is currently active not recruiting. The enrollment target is 500,000 participants. The study started on 2019-11-14. Estimated completion is 2025-02-28.

What conditions does trial NCT04198194 study?

This clinical trial studies the following conditions: Prevention.

What interventions are being tested in trial NCT04198194?

The interventions under investigation include: Predictors of events (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04198194?

This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04198194 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.